Logo

Genelabs' Affiliate Sells Shares Worth $4.3M

Dec 18, 1998
Premium

REDWOOD CITY, Calif.--Gene labs Technologies, a drug discovery firm headquartered here, received $4.3 million form the sale of shares in its Taiwan affiliate, Genelabs Biotechnology. A single investor, Long Bon Development, purchased the shares for $17.50 per share.

Filed under

Informatics
Breaking News
The Scan

For Those Thick Tiger Stripes

Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports.

High GABA Tomatoes

The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan.

Approach for Inclusivity and Diversity

A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos."

Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation

In Science this week: study of how tumors evade the adaptive immune system, and more.